| scholarly article | Q13442814 |
| P2093 | author name string | Dean H Kedes | |
| Thomas J Ellison | |||
| Lynn M Hassman | |||
| P2860 | cites work | Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. | Q24531182 |
| Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection | Q24670607 | ||
| Marginal-zone B cells | Q28201000 | ||
| Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation | Q28236086 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| B cell activation and the establishment of Epstein-Barr virus latency | Q28281625 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease | Q28304633 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus | Q30306907 | ||
| KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice | Q30440843 | ||
| Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation | Q31977172 | ||
| KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia | Q33509506 | ||
| The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases | Q33644236 | ||
| Cellular origin of human B-cell lymphomas. | Q33772424 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma | Q33889296 | ||
| Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. | Q33939333 | ||
| Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice | Q33943771 | ||
| Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication | Q34128791 | ||
| Molecular genetics of immunoglobulins. | Q34167300 | ||
| Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. | Q34259037 | ||
| Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus | Q34333321 | ||
| A mouse model for infectious mononucleosis | Q34644458 | ||
| KSHV/HHV8-associated lymphomas. | Q34711929 | ||
| The human marginal zone B cell | Q35119920 | ||
| Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. | Q35809792 | ||
| Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile | Q35918316 | ||
| Fifty years of multicentric Castleman's disease | Q36069611 | ||
| Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells | Q36366617 | ||
| KSHV vFLIP is essential for the survival of infected lymphoma cells | Q36399405 | ||
| Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia | Q36664300 | ||
| Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. | Q36711639 | ||
| The dynamics of the B follicle: understanding the normal counterpart of B-cell-derived malignancies. | Q36818916 | ||
| Human IgM+CD27+ B cells: memory B cells or "memory" B cells? | Q36853364 | ||
| Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis | Q36882284 | ||
| Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin | Q37010247 | ||
| Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence | Q37157253 | ||
| Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression | Q37169139 | ||
| Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus | Q37273424 | ||
| Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy | Q37366303 | ||
| An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization | Q38349476 | ||
| Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents | Q38887194 | ||
| X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions | Q39858771 | ||
| Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma | Q39881065 | ||
| Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. | Q40002946 | ||
| B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus | Q40110061 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication | Q40644381 | ||
| The Kaposi sarcoma–associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element | Q40758382 | ||
| Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties | Q40802330 | ||
| Ki67: from antibody to molecule to understanding? | Q40848762 | ||
| Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire | Q41505077 | ||
| CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells | Q41767963 | ||
| Isolation and characterization of human tonsil dendritic cells | Q42608616 | ||
| Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients | Q43823829 | ||
| Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application | Q43966225 | ||
| Human tonsillar tissue block cultures differ from autologous tonsillar cell suspension cultures in lymphocyte subset activation and cytokine gene expression. | Q44060550 | ||
| High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. | Q44424254 | ||
| Regulatory role of CD19 molecules in B-cell activation and differentiation | Q44925493 | ||
| Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction | Q44980755 | ||
| Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents | Q45794791 | ||
| Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease. | Q45953695 | ||
| Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production | Q46677350 | ||
| Interleukin-6 is a growth factor for nonmalignant human plasmablasts | Q52021179 | ||
| B-cell neoplasia in man. | Q53596983 | ||
| Maxiprep genomic DNA extractions for molecular epidemiology studies and biorepositories. | Q54473077 | ||
| Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases | Q57952920 | ||
| Picogram per cell determination of DNA by flow cytofluorometry | Q71381146 | ||
| Assessment of cell viability by flow cytometric analysis using DNase exclusion | Q71706005 | ||
| Lymphocyte Subsets in Normal Human Lymphoid Tissues | Q72700201 | ||
| Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice | Q73118585 | ||
| The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells | Q73184792 | ||
| Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation | Q73267742 | ||
| CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling | Q73705592 | ||
| Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen | Q73923367 | ||
| Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts | Q74541237 | ||
| Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival | Q78336747 | ||
| Role of tonsillar IgD+CD27+ memory B cells in humoral immunity against pneumococcal infection | Q79438364 | ||
| Extended depth of field imaging for high speed cell analysis | Q79722363 | ||
| Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD) | Q79786222 | ||
| Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease | Q80432988 | ||
| CD5+ B cells with the features of subepithelial B cells found in human tonsils | Q80577042 | ||
| Detection of herpesvirus type 8 (HHV8) in children's tonsils and adenoids by immunohistochemistry and in situ hybridization | Q81889435 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasmablast | Q66590834 |
| P304 | page(s) | 752-768 | |
| P577 | publication date | 2011-01-18 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation | |
| P478 | volume | 121 |
| Q35382266 | A Kaposi's Sarcoma-Associated Herpesvirus-Encoded Ortholog of MicroRNA miR-155 Induces Human Splenic B-Cell Expansion in NOD/LtSz-scid IL2Rγ null Mice |
| Q28535343 | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency |
| Q38073761 | AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV |
| Q34733560 | Abortive Lytic Reactivation of KSHV in CBF1/CSL Deficient Human B Cell Lines |
| Q38315444 | Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. |
| Q35463816 | Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray |
| Q34103593 | Dendritic cells: key players in human herpesvirus 8 infection and pathogenesis |
| Q33757221 | Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells |
| Q37547223 | Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus |
| Q59351017 | Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus |
| Q47601651 | Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition |
| Q89581789 | Gammaherpesvirus-infected germinal center cells express a distinct immunoglobulin repertoire |
| Q90646331 | Glycoprotein K8.1A of Kaposi's Sarcoma-Associated Herpesvirus Is a Critical B Cell Tropism Determinant Independent of Its Heparan Sulfate Binding Activity |
| Q92255602 | Herpesviruses and the Unfolded Protein Response |
| Q92295697 | How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis |
| Q34130226 | Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma |
| Q40259107 | Human Herpesviruses 6, 7 and 8 in Solid Organ Transplant Recipients |
| Q48188951 | Human Memory B Cells in Healthy Gingiva, Gingivitis, and Periodontitis. |
| Q34237804 | Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcoma |
| Q42273159 | Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients |
| Q64280722 | Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses |
| Q57909946 | In vivo persistence of chimeric virus after substitution of the KSHV LANA DNA binding domain with that of MuHV-4 |
| Q35383336 | Infection of Lymphoblastoid Cell Lines by Kaposi's Sarcoma-Associated Herpesvirus: Critical Role of Cell-Associated Virus |
| Q28080198 | Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host |
| Q35758675 | K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus. |
| Q52586065 | KSHV induces immunoglobulin rearrangements in mature B lymphocytes |
| Q39357797 | KSHV infection of B-cell lymphoma using a modified KSHV BAC36 and coculturing system |
| Q34417383 | KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies. |
| Q90134505 | KSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap |
| Q37418380 | Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line |
| Q38114627 | Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)—an update |
| Q36607305 | Kaposi's Sarcoma-Associated Herpesvirus Oncoprotein K13 Protects against B Cell Receptor-Induced Growth Arrest and Apoptosis through NF-κB Activation |
| Q34261905 | Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication |
| Q30369871 | Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells. |
| Q38859450 | Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin |
| Q59355341 | LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells |
| Q33946055 | Lactoferrin deficiency promotes colitis-associated colorectal dysplasia in mice |
| Q37910910 | Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge |
| Q37252649 | Latency locus complements MicroRNA 155 deficiency in vivo. |
| Q35158385 | Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors |
| Q38863770 | Multicentric Castleman disease: Where are we now? |
| Q40098067 | Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo |
| Q34426495 | Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. |
| Q38016546 | Oral HIV‐associated Kaposi sarcoma |
| Q84965891 | Pleural primary effusion lymphoma in an elderly patient |
| Q36736361 | Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells |
| Q48424659 | Primary effusion lymphoma involving cerebrospinal fluid, deep cervical lymph nodes and adenoids. Report of a case supporting the lymphatic connection between brain and lymph nodes |
| Q39271443 | Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas |
| Q36546999 | Professional antigen presenting cells in human herpesvirus 8 infection |
| Q38021339 | Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. |
| Q38449592 | Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis |
| Q34130213 | The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation |
| Q92156491 | The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases |
| Q37254263 | The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1. |
| Q30425660 | Tracking expression and subcellular localization of RNA and protein species using high-throughput single cell imaging flow cytometry |
| Q47382558 | Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease |
| Q34614553 | Unraveling virus-induced lymphomagenesis |
| Q26740703 | Update and new approaches in the treatment of Castleman disease |
| Q36761560 | Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. |
| Q24607716 | Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A |
| Q42251926 | YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions |
| Q35099427 | xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases |
Search more.